Federated Hermes’s NEVRO CORP. NVRO Stock Holding History

Federated Hermes’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-55,679	Closed	-$207K	–	2225
2024 Q4	$207K	Sell	55,679 -188,515	-77%	-$870K	﹤0.01%	1479
2024 Q3	$1.37M	Sell	244,194 -151,940	-38%	-$1.06M	﹤0.01%	1034
2024 Q2	$3.34M	Sell	396,134 -42,801	-10%	-$456K	0.01%	806
2024 Q1	$6.34M	Buy	438,935 +7,782	+2%	+$129K	0.01%	674
2023 Q4	$9.28M	Buy	431,153 +341,343	+380%	+$6.09M	0.02%	571
2023 Q3	$1.73M	Sell	89,810 -20,514	-19%	-$438K	﹤0.01%	971
2023 Q2	$2.8M	Sell	110,324 -448,694	-80%	-$13M	0.01%	854
2023 Q1	$20.2M	Buy	559,018 +32,790	+6%	+$1.15M	0.05%	392
2022 Q4	$20.8M	Sell	526,228 -306,702	-37%	-$12.8M	0.06%	373
2022 Q3	$38.8M	Sell	832,930 -248,871	-23%	-$11.6M	0.11%	225
2022 Q2	$47.4M	Buy	1,081,801 +807,678	+295%	+$44.4M	0.13%	205
2022 Q1	$19.8M	Buy	274,123 +238,677	+673%	+$17.2M	0.04%	443
2021 Q4	$2.87M	Buy	+35,446	New	+$3.55M	0.01%	959
2021 Q2	–	Sell	-1,987	Closed	-$277K	–	2355
2021 Q1	$277K	Sell	1,987 -7,326	-79%	-$1.2M	﹤0.01%	1658
2020 Q4	$1.61M	Buy	+9,313	New	+$1.51M	﹤0.01%	1146
2020 Q3	–	Sell	-2	Closed	-$1K	–	2364
2020 Q2	$1K	Sell	2 -637	-100%	-$75.6K	﹤0.01%	2186
2020 Q1	$64K	Sell	639 -91,841	-99%	-$11M	﹤0.01%	1688
2019 Q4	$10.9M	Buy	92,480 +48,349	+110%	+$4.79M	0.02%	577
2019 Q3	$3.79M	Buy	+44,131	New	+$3.34M	0.01%	840
2019 Q1	–	Sell	-428,721	Closed	-$16.7M	–	2243
2018 Q4	$16.7M	Sell	428,721 -60,387	-12%	-$2.68M	0.05%	352
2018 Q3	$27.9M	Buy	489,108 +180,008	+58%	+$11.3M	0.07%	285
2018 Q2	$24.7M	Buy	309,100 +21,400	+7%	+$1.78M	0.07%	216
2018 Q1	$24.9M	Hold	287,700	–	–	0.07%	210
2017 Q4	$19.9M	Hold	287,700	–	–	0.06%	255
2017 Q3	$26.1M	Hold	287,700	–	–	0.08%	219
2017 Q2	$21.4M	Sell	287,700 -29,385	-9%	-$2.35M	0.06%	259
2017 Q1	$29.7M	Hold	317,085	–	–	0.08%	206
2016 Q4	$23M	Buy	317,085 +13,800	+5%	+$1.18M	0.07%	248
2016 Q3	$31.7M	Sell	303,285 -323	-0.1%	-$29.2K	0.09%	173
2016 Q2	$22.4M	Buy	303,608 +34,708	+13%	+$2.36M	0.07%	248
2016 Q1	$15.1M	Buy	+268,900	New	+$15.9M	0.05%	324
2015 Q2	–	Sell	-49,800	Closed	-$2.39M	–	2090
2015 Q1	$2.39M	Sell	49,800 -18,700	-27%	-$811K	0.01%	898
2014 Q4	$2.65M	Buy	+68,500	New	+$2.16M	0.01%	847

Other funds holding NVRO

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Federated Hermes's NVRO Position: Q1 2025 in Review

Federated Hermes sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 55,679 shares — an estimated $207K sold.

Federated Hermes first reported a position in NVRO in Q4 2014 and held it in 33 quarters. The position peaked at $47.4M in Q2 2022. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

Federated Hermes reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
Federated Hermes sold 55,679 NEVRO CORP. shares in Q1 2025, an estimated $207K.
Federated Hermes first reported a position in NEVRO CORP. in Q4 2014 and held it in 33 quarters.
Federated Hermes's NEVRO CORP. position peaked at $47.4M in Q2 2022.
126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.